Microfluidics Devices include micro volume manipulation of fluids typically in the sub-millimeter scale, with precision control. Microfluidics devices is a multidisciplinary field intersecting engineering, physics, chemistry, nanotechnology, and others. The Microfluidic Devices Market is anticipated to generate $13.24 billion with a CAGR growth of 19.7% during the forecast period of 2016 to 2024.
Global Microfluidic Devices Market – Key Players
Some of the major players in this market are:
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Abbott
- Raindance Technologies, Inc.
- Agilent technologies, Inc.
- Cepheid
- Siemens Healthcare GmbH
- Dolomite Centre
- Fluidigm Corporation
- Micronit microfluidics
Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/954
Global Microfluidic Devices Market – Dynamics
Drivers
Increasing applications with characteristic low fluids volumes manipulation, multiplexing, such as biotechnology, drug discovery, chemical analysis and others are chief drivers of the market. Growing adoption of automation, high-throughput screening, and other in laboratory and manufacturing is another driver of the market. Growing R&D investment in life sciences, pharmaceuticals, and point of care testing are demand led drivers of the market. Technical advantages over conventionally sized systems such as parameter control, automation, multitasking such as processing as well as analyzing, are also driving the demand especially in research.
Restraints
High cost of devices, operating issues such as proprietary technology resulting in high switching costs, and others are constraining the market. Regulatory challenges, and operational issues such as high-pressure requirements, rupture and leakages, clogging and low robustness to impurities sensitivity and geometrical problem in construction and resource intensive maintenance are other strong restraints on the market.
Industry News:
December 13, 2018 – Researchers from the Massachusetts Institute of Technology (MIT) published their study of a novel 3-D printed microfluidic device that they have invented. The new microfluidic device can simulate cancer treatments on biopsied tumor tissue, so clinicians can better examine how individual patients will respond to different therapeutics before administering a single dose.
November 26, 2018 – The University of Toronto (Canada) announced its partnership with Canada’s National Research Council (CNRC) to create a national innovation hub focused on microfluidics, a field in which tiny amounts of fluid are manipulated in small-scale devices to create everything from portable diagnostic “labs” to repair kits for human organs.
The collaboration will be called as the Centre for Research and Applications in Fluidic Technologies (CRAFT) and will combine the talents of U of T microfluidic experts and NRC scientists in a bid to catalyze new discoveries and scale up production of existing prototypes to deliver higher quality patient care at a lower cost. CRAFT will be jointly funded by both partners with a $22 million investment over five years.
Nov 2016 – Danaher Corporation acquired Cepheid.
Jun 2016 – Luminex Corporation acquired Nanosphere, Inc.
April 2014 – Roche acquired IQuum for USD 275 million upfront and USD 175 million in contingent product liabilities, which is poised to strengthen its offerings in molecular diagnostics microfluidic devices. Roche marks the entry in point of care molecular diagnostics devices.
January 2014 – bioMérieux, acquired BioFire Diagnostics Inc., maker of automated PCR molecular biology systems.
Global Microfluidic Devices Market – Segmentation
Microfluidic Devices Market has been segmented on the basis of industry, which comprises of in-vitro diagnostics, pharmaceutical, medical devices. On basis of the materials, market is segmented into polymer, glass, silicon. On the basis of the application, the market is segmented into clinical, and veterinary diagnostics, point of care, analytical devices, drug delivery, environmental, and industrial applications. On the basis of geographic region, the microfluidic devices market is segmented into three key regions: North America, Europe, and Asia.
Global Microfluidic Devices Market – Regional Analysis
The Global Microfluidic Devices Market is segmented into North America, Europe, and Asia Pacific.
North America was leading market player across the globe in 2016 and is expected to reach USD 4.88 billion by the end of the forecasted period.
Europe is the second largest region in the Global Microfluidic Devices Market, which is expected to grow at a CAGR of 22.8%.
Asia Pacific region is expected to be the fastest growing region in the global microfluidic devices market.
Browse Complete 86 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/microfluidic-devices-market-954
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/microfluidic-devices-market-954